Discover trends, market shifts, and competitive outlooks for the self-administered parenteral industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Self-Administered Parenteral Market Growth Performance Trended Historically, And What Lies Ahead?

In the past few years, there has been robust growth in the self-administered parenteral market. The market’s size is predicted to surge from $24.57 billion in 2024 to $26.04 billion in 2025, signifying a Compound Annual Growth Rate (CAGR) of 6.0%. Historical growth can be traced back to factors such as an increase in chronic diseases, an aging population, government initiatives, patient education and support programs, in addition to the escalating incidences of bone disorders.

The market size of self-administered parenteral therapies is projected to observe robust growth over the coming years, ballooning to $31.18 billion in 2029 at a CAGR of 4.6%. Factors contributing to growth during the forecast period include the rising preference amongst patients for home healthcare, developments in telemedicine and remote patient supervision, initiatives focused on patient education and support, and the growth of personalized medicine. Noteworthy trends for the forecast period include the amalgamation of digital health solutions, custom drug delivery systems, the advent of targeted therapies, and advancements in biologics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Self-Administered Parenteral Market?

The rise in chronic diseases is anticipated to drive the expansion of the self-administered parenteral market in the future. Chronic diseases are enduring health conditions that typically progress gradually and often necessitate continuous management and treatment. Self-administered parenteral products are employed in treating chronic diseases independently, leading to a noticeable enhancement in adherence compared to orally administered medication. For example, in January 2023, the National Institutes of Health, a government agency in the US, projected that there will be a 99.5% increase in the population aged 50 or above with at least one chronic disease, from 71.522 million in 2020 to 142.66 million by 2050. Thus, the rising prevalence of chronic diseases is fuelling the expansion of the self-administered parenteral market.

What Segment Types Define the Self-Administered Parenteral Market Structure?

The self-administered parenteral market covered in this report is segmented –

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products

2) By Usage: Disposable, Reusable

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels

4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Subsegments:

1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes

2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors

3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors

4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Self-Administered Parenteral Market?

North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Self-Administered Parenteral Market?

Firms ruling the self-administered parenteral market, such as Coherus BioSciences Inc, are putting their efforts towards the innovation of products like the UDENYCA autoinjector to supply more options and independence, hence making treatment more feasible for patients. An autoinjector is a medicinally constructed implement planned to distribute one dosage of a specific medication. This is a straightforward device that functions by applying pressure to the skin. Coherus BioSciences Inc, an American biotech firm, introduced the UDENYCA autoinjector, a self-administered parenteral drug in the US market in May 2023. With a preloaded single-dose autoinjector for pegfilgrastim, the UDENYCA aims to ensure a user-friendly, efficient, and reliable dosage delivery upon skin contact. It comes with features that ensure successful delivery like fast dosing, easy-to-understand design, dual coverage, suitability for at-home or office use, and lessens the danger of febrile neutropenia.

View the full report here:

https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

What Is the Definition of the Self-Administered Parenteral Market?

Self-administered parenteral refers to the administration of medication or substances into the body by oneself through injection methods. This method provides patients with greater autonomy and convenience, allowing them to manage the conditions in a more flexible and comfortable environment without the need for frequent visits to healthcare facilities.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model